Evidence map›Paper›PMID 41893271›Full record

ArticleMembranes2026

Impedance-Controlled Molecular Transport Across Multilayer Skin Membranes.

Slobodanka Galovic, Milena Cukic Radenkovic, Edin Suljovrujic

Abstract read
In one paragraph

Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Slobodanka GalovicVinca Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 522, 11001 Belgrade, Serbia.ORCID 0000-0002-6728-8868
Milena Cukic RadenkovicInstitute of Computational Life Sciences, School of Life Sciences and Facility Management, ZHAW Zurich University of Applied Sciences, 8820 Wädenswil, Switzerland.ORCID 0000-0002-9162-987X
Edin SuljovrujicVinca Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 522, 11001 Belgrade, Serbia.ORCID 0000-0001-8774-4341

Funding

Ministry of Science, Technological Development and Innovations of the Republic of Serbia . Contract No. 451-03-136/2025-03/200017
6 · The paper itself

Abstract

Analytical models of transdermal drug delivery (TDD) often represent deeper skin layers using ideal sink assumptions or phenomenological interfacial resistances. While mathematically convenient, these approaches obscure the physical role of the dermis and hypodermis in controlling molecular transport. Here, we develop an impedance-based analytical model for diffusion across multilayer skin membranes, in which the epidermal barrier is dynamically coupled to a finite diffusive backing layer representing the dermis-hypodermis composite. Diffusion impedance links transport conductivity, storage capacity, and layer thickness, while preserving continuity of concentration and flux at all interfaces. Closed-form expressions in the Laplace domain describe concentration fields and interfacial fluxes, and cumulative drug uptake is computed in the time domain via inverse Laplace transformation. The model identifies distinct short- and long-time transport regimes. Commonly used Dirichlet and Robin boundary conditions emerge as limiting cases but cannot reproduce the regime-dependent behavior of a backing layer. In particular, Robin formulations reduce the backing layer to a constant effective resistance, neglecting its storage capacity and time-dependent impedance. By replacing ad hoc boundary conditions with a physically grounded impedance framework, this approach provides a unified and extensible method for analyzing multilayer transport systems, including extensions to anomalous or memory-dependent diffusion.

Indexed as

cumulative drug uptakediffusion impedancemultilayer diffusionskin membranetransdermal drug delivery

Identifiers

PMID41893271
PMCPMC13027749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.